Common cell-cycle biomarkers in both lung and bladder cancers
2/01/2014
A University of Colorado Cancer Center study published in the journal PLoS ONE shows that bladder and lung cancers are marked by shared differences in the genetics that control the cell cycle. Measuring these genetic signatures could allow doctors to refine a patient's prognosis, choose appropriate treatments, and perhaps offer new treatments that target these shared genetic abnormalities.
Thirdhand smoke linked to liver, lung and skin problems
1/31/2014
While the physical evidence of secondhand smoke can be seen wafting through the air, thirdhand smoke is a more clandestine health threat. The invisible remnant of tobacco smoke that clings to surfaces and even dust, thirdhand smoke is linked to several adverse health effects in a new study published in PLOS ONE.
Antioxidants may speed up lung cancer progression
1/31/2014
Numerous studies have shown that antioxidants may halt cancer progression. But a new study from researchers at the Sahlgrenska Academy at the University of Gothenburg in Sweden has found that antioxidants may actually speed up the progression of lung cancer.The findings are published in the journal Science Translational Medicine.
Thirdhand smoke linked to liver, lung and skin problems
1/31/2014
While the physical evidence of secondhand smoke can be seen wafting through the air, thirdhand smoke is a more clandestine health threat. The invisible remnant of tobacco smoke that clings to surfaces and even dust, thirdhand smoke is linked to several adverse health effects in a new study published in PLOS ONE.
Antioxidants may speed up lung cancer progression
1/31/2014
Numerous studies have shown that antioxidants may halt cancer progression. But a new study from researchers at the Sahlgrenska Academy at the University of Gothenburg in Sweden has found that antioxidants may actually speed up the progression of lung cancer.The findings are published in the journal Science Translational Medicine.
NICE gives go ahead to NeoTract's groundbreaking UroLift® prostate implant
1/31/2014
NeoTract, Inc., has announced that the UK's National Institute for Health and Clinical Excellence (NICE) has issued an Interventional Procedure Guidance (IPG) approving the UroLift prostatic urethral lift implant for use by UK doctors. The NICE guidance was made following consultations with independent clinical experts and a literature review.
Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study
1/31/2014
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.The figures were presented by Norwegian cancer researcher Sophie Fosså at an international conference sponsored by the American Society of Clinical Oncology (ASCO) in San Francisco this week.
Genomic analysis reveals 2 separate molecular profiles of invasive bladder cancer
1/31/2014
In the first whole-genome analysis conducted through the Roswell Park Cancer Institute (RPCI) Center for Personalized Medicine, researchers report that invasive bladder cancers demonstrate two distinct patterns of genetic alteration, one of which may result from defects in cells' ability to replicate.
Targeting 'sleeper agent' cells in bones of prostate cancer patients
1/31/2014
Dormant prostate cancer cells in bone tissue can be reawakened to cause secondary tumours, according to new research published in Endocrine-Related Cancer. Targeting the wake-up call could prevent metastasis and improve prostate cancer survival rates.
Immune cell response triggered by vaccine used to treat cervical precancers
1/31/2014
Preliminary results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself.